re: bronchitoltm approved for patient use In particular, Bronchitol has been shown to dramatically
increase mucus clearance from the lungs and significantly improve quality of life for people
with bronchiectasis. Pharmaxis’ Phase II clinical trials for bronchiectasis are complete and
Phase III pre-registration trials are beginning.
the biotech sector will soon be pumping.obj,pxs,prr etc
re: bronchitoltm approved for patient use In particular,...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SNT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.8¢ |
Change
-0.002(6.67%) |
Mkt cap ! $36.13M | |||
| Open | High | Low | Value | Volume |
| 3.0¢ | 3.0¢ | 2.8¢ | $208.0K | 7.159M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 1443885 | 2.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.9¢ | 1091321 | 2 |
View Market Depth
| Last trade - 16.10pm 08/08/2024 (20 minute delay) ? |
| SNT (ASX) Chart |